Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
HyBryte (synthetic hypericin)
i
Other names:
SGX301
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Soligenix
Drug class:
Photosensitizer, Cell death stimulant
Related drugs:
‹
verteporfin (10)
5-ALA with CV01 (0)
ALA sonodynamic therapy (0)
aminolevulinic acid (0)
fimaporfin (0)
hexaminolevulinate (0)
temoporfin (0)
talaporfin (0)
methyl aminolevulinate hydrochloride 16.8% cream (0)
porfimer sodium (0)
REM-001 therapy (0)
padeliporfin (0)
DTBF (0)
X-PACT (0)
TEQ103 (1)
CG0070 (1)
DNX-2401 (1)
AMUN-003 (0)
Ad-p53 gene therapy (0)
BI 1821736 (0)
CP-506 (0)
TRX-E-002-1 (0)
Clostridium novyi-NT (0)
DNX-2440 (0)
KM1 (0)
MV-NIS (0)
ruxotemitide (0)
R130 (0)
RGV004 (0)
TG6050 (0)
VCN-01 (0)
YSCH-01 (0)
BBI-503 (0)
bendamustine hydrochloride (0)
ColoAd1 (0)
PT-112 (0)
RP1 (0)
verteporfin (10)
5-ALA with CV01 (0)
ALA sonodynamic therapy (0)
aminolevulinic acid (0)
fimaporfin (0)
hexaminolevulinate (0)
temoporfin (0)
talaporfin (0)
methyl aminolevulinate hydrochloride 16.8% cream (0)
porfimer sodium (0)
REM-001 therapy (0)
padeliporfin (0)
DTBF (0)
X-PACT (0)
TEQ103 (1)
CG0070 (1)
DNX-2401 (1)
AMUN-003 (0)
Ad-p53 gene therapy (0)
BI 1821736 (0)
CP-506 (0)
TRX-E-002-1 (0)
Clostridium novyi-NT (0)
DNX-2440 (0)
KM1 (0)
MV-NIS (0)
ruxotemitide (0)
R130 (0)
RGV004 (0)
TG6050 (0)
VCN-01 (0)
YSCH-01 (0)
BBI-503 (0)
bendamustine hydrochloride (0)
ColoAd1 (0)
PT-112 (0)
RP1 (0)
›
Associations
News
Trials
Filter by
Latest
3d
FLASH2: Confirmatory Study of Topical HyBryte™ Vs. Placebo for the Treatment of CTCL (clinicaltrials.gov)
P3, N=80, Recruiting, Soligenix | Not yet recruiting --> Recruiting
3 days ago
Enrollment open
|
HyBryte (synthetic hypericin)
6ms
HyBryte (Synthetic Hypericin) Versus Valchlor (Mechlorethamine) in the Treatment of CTCL (clinicaltrials.gov)
P2, N=10, Completed, Soligenix | Recruiting --> Completed
6 months ago
Trial completion
|
HyBryte (synthetic hypericin) • Valchlor (mechlorethamine gel)
6ms
FLASH2: Confirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCL (clinicaltrials.gov)
P3, N=80, Not yet recruiting, Soligenix
6 months ago
New P3 trial
|
HyBryte (synthetic hypericin)
1year
HyBryte (Synthetic Hypericin) Versus Valchlor (Mechlorethamine) in the Treatment of CTCL (clinicaltrials.gov)
P2, N=10, Recruiting, Soligenix | Not yet recruiting --> Recruiting
1 year ago
Enrollment open
|
HyBryte (synthetic hypericin) • Valchlor (mechlorethamine gel)
1year
HyBryte (Synthetic Hypericin) Versus Valchlor (Mechlorethamine) in the Treatment of CTCL (clinicaltrials.gov)
P2, N=10, Not yet recruiting, Soligenix
1 year ago
New P2 trial
|
HyBryte (synthetic hypericin) • Valchlor (mechlorethamine gel)
1year
Treatment of Mycosis Fungoides With Hypericin Ointment and Visible Light (clinicaltrials.gov)
P2, N=50, Recruiting, Ellen Kim, MD | Not yet recruiting --> Recruiting
1 year ago
Enrollment open
|
HyBryte (synthetic hypericin)
over1year
Treatment of Mycosis Fungoides With Hypericin Ointment and Visible Light (clinicaltrials.gov)
P2, N=50, Not yet recruiting, Ellen Kim, MD
over 1 year ago
New P2 trial
|
HyBryte (synthetic hypericin)
Share via
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login